Low-grade central osteosarcoma. Review
- Authors: Rogozhin D.V.1,2, Konovalov D.M.1,2, Talalaev A.G.1,2, Roschin V.Y.1,2, Bolshakov N.A.1,2, Tikhonova M.V.1,2, Remizov A.N.1,2
-
Affiliations:
- Russian Children’s Clinical Hospital
- Research Center of Pediatric Hematology, Oncology and Immunology
- Issue: Vol 8, No 3 (2016)
- Pages: 16-21
- Section: BONE SARCOMAS
- Published: 22.10.2016
- URL: https://sarbon.abvpress.ru/jour/article/view/360
- ID: 360
Cite item
Full Text
Abstract
Low-grade central osteosarcoma is a rare subtype of intramedullary osteosarcoma (approximately 1% of all osteosarcomas) that characterized histologically by a spindle cell proliferation associated with trabecular bone formation, and is usually located in the long bones with a predilection for the distal femur and proximal tibia. It has the potential to recur, dedifferentiate, and metastasize subsequent to surgical treatment. Sometimes it is difficult to make a diagnosis and differentiate it with fibrous dysplasia and desmoplastic fibroma. In such cases, careful radiological interpretation is helpful. This tumor usually carries a good prognosis.
About the authors
D. V. Rogozhin
Russian Children’s Clinical Hospital;Research Center of Pediatric Hematology, Oncology and Immunology
Author for correspondence.
Email: Pathol.777@mail.ru
Moscow
Russian FederationD. M. Konovalov
Russian Children’s Clinical Hospital;Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationA. G. Talalaev
Russian Children’s Clinical Hospital;Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationV. Yu. Roschin
Russian Children’s Clinical Hospital;Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationN. A. Bolshakov
Russian Children’s Clinical Hospital;Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationM. V. Tikhonova
Russian Children’s Clinical Hospital;Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationA. N. Remizov
Russian Children’s Clinical Hospital;Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationReferences
Supplementary files


